Medical Device | October 10, 2025
Integris Medtech files DRHP with SEBI for IPO
The company plans to use the funds raised from the net proceeds to repay or prepay certain loans
The company plans to use the funds raised from the net proceeds to repay or prepay certain loans
IMCD engaged with manufacturers, formulators, and brand leaders, offering valuable insights into evolving consumer trends
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
An estimated 50% of patients with ER+, HER2– metastatic breast cancer will develop an ESR1 mutation during or after exposure to an aromatase inhibitor
The new site enables end-to-end production of viral vector gene therapies
The Phase Ib MAD study is a randomized, double-blind, placebo-controlled trial conducted in the United States
The lab will facilitate the development of herbal and natural-based solutions
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
Ascletis announces ultra-long-acting subcutaneous depot maintenance formulation of small molecule GLP-1R agonist ASC30 with 75-Day observed half-life in participants with obesity
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
Subscribe To Our Newsletter & Stay Updated
